Zydus receives approval from USFDA for Mirabegron Extended-Release Tablets
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urinary incontinence, urgency, and frequency
Roy is the right successor to lead Philips’ efforts to help improve the health and well-being of people globally
The booster vaccination trial is still ongoing and further data will provide more information around safety and efficacy.
Sildenafil for Oral Suspension had annual sales of USD 65 million in the United States according to IQVIA data (IQVIA MAT Aug 2022).
Mirabegron Extended-Release Tablets, 25 mg and 50 mg, had estimated annual sales of US $2.4 billion in US
In the next six months, the program aims to screen 4,000 women from underprivileged communities in and around Mathura
He is a seasoned professional having worked in reputed corporates in API business with over 35+ years of experience covering manufacturing, general management, and business
Julie Brown is currently Chief Operating and Financial Officer, Burberry Group.
Subscribe To Our Newsletter & Stay Updated